KayoThera

KayoThera, Inc. is an early-stage therapeutic company focused on developing novel cancer immunotherapy drugs. KayoThera is developing treatments for advanced and metastatic cancers, including breast cancer, lung cancer, pancreatic cancer, colorectal cancer, brain cancer, and kidney cancer. The company was initially funded by Foundation Venture Capital Group (FVCG).